(Q61966099)
Statements
A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Glimepiride as Add-on Therapy to Metformin in Patients With Type 2 Diabetes (English)
0 references
February 2013
0 references
July 2014
0 references
0
0 references
18 year
0 references
80 year
0 references